SPRY- Ars Pharmaceuticals, Inc.
Ars Pharmaceuticals, Inc. (SPRY) has 8 insiders with recent SEC Form 4 filings, including 0 buys and 23 sells. SPRY is classified in the Biotechnology industry within the Health Care sector.
Insider Ownership
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| Dir | 4.47M | $23.98M | - | |
| CEO | 875.0K | $4.69M | - | |
| Other | 240.0K | $1.29M | - | |
| CFO | 240.0K | $1.29M | - | |
| COO | 240.0K | $1.29M | - |
Activity
Buys and sells only
Transactions
10 filings · page 3
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec 13, 2024 | Chakma Justin81 | Chief Business Officer | Sale+OE | 144,605 | $12.23 | $1,768,092.94 | -34.6% | +0.4% | -13.9% | |
| Dec 12, 2024 | Dorsey Brian57 | Chief Operating Officer | Sale+OE | 40,000 | $12.35 | $493,858.50 | -76.9% | -2.6% | -19.0% | |
| Dec 10, 2024 | Chakma Justin81 | Chief Business Officer | Sale+OE | 50,000 | $13.15 | $657,625.00 | -26.8% | -16.4% | -19.4% | |
| Dec 10, 2024 | Tanimoto Sarina54 | Chief Medical Officer | Sell | 100,000 | $13.16 | $1,316,420.00 | -4.0% | -16.4% | -19.4% | |
| Dec 10, 2024 | Lowenthal Richard E54 | President And CEO | Sell | 100,000 | $13.16 | $1,316,420.00 | -4.0% | -16.4% | -19.4% | |
| Dec 6, 2024 | Chakma Justin81 | Chief Business Officer | Sale+OE | 144,640 | $14.11 | $2,041,200.04 | -26.1% | -23.0% | -29.2% | |
| Dec 4, 2024 | Shawver Laura56 | Director | Sale+OE | 200,000 | $13.44 | $2,688,750.95 | -19.2% | -27.1% | -30.9% | |
| Dec 4, 2024 | Karas Eric76 | Chief Commercial Officer | Sale+OE | 10,000 | $14.04 | $140,423.37 | -46.8% | -27.1% | -30.9% | |
| Dec 3, 2024 | Chakma Justin81 | Chief Business Officer | Sale+OE | 90,000 | $13.43 | $1,208,619.00 | -24.8% | -25.2% | -29.8% | |
| Nov 27, 2024 | Chakma Justin81 | Chief Business Officer | Sell | 100,000 | $14.12 | $1,411,742.12 | -16.6% | -27.3% | -34.3% |